📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates. (2016)

First Author: Calvopiña K

Attributed to: UoOxford Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.00371-16

PubMed Identifier: 27139464

Publication URI: http://europepmc.org/abstract/MED/27139464

Type: Journal Article/Review

Volume: 60

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 7

ISSN: 0066-4804